For a year I talked about Reliq Health Technologies (RHT.V) being a case of not if but when.
For a year I talked about RHT’s CEO Lisa Crossley being a great hire with a great resume and her being destined to succeed.
For a year I talked about their technology and how much it’s needed in the US health system, and how it will save lives and massive bucks.
For a year, the stocks around ten cents a share and nobody paid any heed.
But then, once sunny summer’s day, RHT put out a news release that one of its pilot projects had moved into an executed sales agreement, and the stock rumbled. And then they announced the money had landed and it began to rev.
Now? It’s in full roar, the company has raised five million, and this little multi-pivoted company that message board knuckleheads had dismissed as a pump, that investors were too frightened to go in on, that nobody paid attention to… now you pay a premium for a seat.
Today, RHT stock hit $0.78, barley six weeks after $0.28 became a distant memory. It’s trading like a blockchain stock, but has actual money and sales contracts behind it.
I’m not going to repeat all the things I’ve said in the past about the opportunity here, I’m just going to wallow for a second in the knowledge that faith is sometimes rewarded, and that when a company does what it says it will, when its people achieve what their experience says they can achieve, and when a product is inherently valuable and good, you should sometimes just shut up and buy in.
Well played, RHT.
— Chris Parry
FULL DISCLOSURE: Reliq Health Technologies is a former Equity.Guru client, who we continue to talk about because the mission is not yet complete.